Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMI ORGANICS vs CONCORD DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMI ORGANICS CONCORD DRUGS AMI ORGANICS/
CONCORD DRUGS
 
P/E (TTM) x - 13.3 - View Chart
P/BV x 20.9 0.9 2,211.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMI ORGANICS   CONCORD DRUGS
EQUITY SHARE DATA
    AMI ORGANICS
Mar-21
CONCORD DRUGS
Mar-21
AMI ORGANICS/
CONCORD DRUGS
5-Yr Chart
Click to enlarge
High RsNA33 0.0%   
Low RsNA13 0.0%   
Sales per share (Unadj.) Rs108.158.8 184.0%  
Earnings per share (Unadj.) Rs17.13.8 456.5%  
Cash flow per share (Unadj.) Rs18.55.3 347.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00- 
Book value per share (Unadj.) Rs53.030.6 173.0%  
Shares outstanding (eoy) m31.508.74 360.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x00.4 0.0%   
Avg P/E ratio x06.1 0.0%  
P/CF ratio (eoy) x04.3 0.0%  
Price / Book Value ratio x00.7 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m0201 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m21035 606.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,406514 663.2%  
Other income Rs m141 1,452.6%   
Total revenues Rs m3,420515 664.7%   
Gross profit Rs m80270 1,147.8%  
Depreciation Rs m4214 306.8%   
Interest Rs m5614 395.6%   
Profit before tax Rs m71743 1,671.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m17710 1,755.1%   
Profit after tax Rs m54033 1,645.3%  
Gross profit margin %23.513.6 173.1%  
Effective tax rate %24.723.5 105.0%   
Net profit margin %15.96.4 248.1%  
BALANCE SHEET DATA
Current assets Rs m2,162360 600.5%   
Current liabilities Rs m1,660162 1,022.7%   
Net working cap to sales %14.738.5 38.3%  
Current ratio x1.32.2 58.7%  
Inventory Days Days110 3,891.8%  
Debtors Days Days1291,473 8.8%  
Net fixed assets Rs m1,970139 1,420.4%   
Share capital Rs m31587 360.2%   
"Free" reserves Rs m1,354180 751.4%   
Net worth Rs m1,669268 623.7%   
Long term debt Rs m7266 12,047.1%   
Total assets Rs m4,133499 828.5%  
Interest coverage x13.84.0 342.3%   
Debt to equity ratio x0.40 1,931.6%  
Sales to assets ratio x0.81.0 80.1%   
Return on assets %14.49.4 153.0%  
Return on equity %32.312.3 263.8%  
Return on capital %32.320.9 154.7%  
Exports to sales %50.80-   
Imports to sales %14.60-   
Exports (fob) Rs m1,729NA-   
Imports (cif) Rs m499NA-   
Fx inflow Rs m1,7290-   
Fx outflow Rs m5270-   
Net fx Rs m1,2020-   
CASH FLOW
From Operations Rs m27116 1,679.8%  
From Investments Rs m-1,004-37 2,738.4%  
From Financial Activity Rs m72121 3,476.8%  
Net Cashflow Rs m-110 -4,943.5%  

Share Holding

Indian Promoters % 41.1 49.0 83.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.0 -  
FIIs % 2.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 59.0 51.0 115.6%  
Shareholders   93,922 3,047 3,082.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMI ORGANICS With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

4 Reasons Why Sensex Rallied 1,534 Points Today(0)

Bulls marked a strong comeback today as Indian share markets ended nearly 3% higher. After opening the day higher, equity markets extended gains as the session progressed and ended near the day's high.

Related Views on News

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMI ORGANICS SHARE PRICE


May 20, 2022 (Close)

TRACK AMI ORGANICS

  • Track your investment in AMI ORGANICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMI ORGANICS - LAURUS LABS COMPARISON

COMPARE AMI ORGANICS WITH

MARKET STATS